Literature DB >> 17593915

Does rosiglitazone adversely affect bone formation and bone mineral density in postmenopausal women?

Ann V Schwartz1, Steven R Cummings.   

Abstract

Entities:  

Year:  2007        PMID： 17593915     DOI： 10.1038/ncpendmet0562

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  2 in total

1.  Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

Authors:  Yoon K Loke; Sonal Singh; Curt D Furberg
Journal:  CMAJ       Date:  2008-12-10       Impact factor: 8.262

2.  Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala).

Authors:  Peyman Mottaghi
Journal:  J Res Med Sci       Date:  2013-04       Impact factor: 1.852
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.